Delivery Order SPE2DB22D1106-SPE2DB25FEVB5
Award Date
6/25/25
Potential Completion Date
6/26/25
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,345.50, is for the delivery of 4567606287 units of 400 mg Moxifloxacin HCL tablets. The contract has an ultimate completion date of March 19, 2025 and was awarded on March 18, 2025. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,285.44 firm fixed-price delivery order is for the supply of 4,568,092,674 units of the antibiotic medication Moxifloxacin Hydrochloride 400 mg Tablets. The award is not set aside and is part of a larger indefinite delivery contract (IDC) valued at $999,999,999.00 held by AmerisourceBergen with DLA Troop Support...
This is a $2,207.88 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Moxifloxacin HCL 400 mg tablets. The contract has an ultimate completion date of June 30, 2025 and is not set aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,867.20 Firm Fixed Price Delivery Order contract is for the supply of 4,563,604,495 units of the pharmaceutical product Moxifloxacin HCL 400 mg Tablets, with a completion date of February 9, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has an Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,585.38 firm fixed-price delivery order is for the supply of Moxifloxacin Hydrochloride, a broad-spectrum antibiotic medication. The contract has an ultimate completion date of February 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,954,858 units of Moxifloxacin HCL 400 mg tablets. This $1,011.77 firm fixed price award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 held by Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceuticals...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,555.04, is for the delivery of 4567437079 - Moxifloxacin HCL 400 mg Tablet UD 50s, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 4, 2025. The contract is not designated with a set-aside....
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,127.06 contract is for the delivery of 4,567,919,068 units of the antibiotic Moxifloxacin HCL 400 mg tablets. The contract has an ultimate completion date of April 16, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
This federal contract award is a delivery order worth $1,754.76 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The award is for the supply of 50 tablets of Moxifloxacin HCL 400 mg, a medication, to the Defense Logistics Agency (DLA), which is the supply and logistics agency for the U.S. Department of Defense. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of June...
This federal contract award was made by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $1,940.89 for the supply of 4568252897 - MOXIFLOXACIN 400 MG/250 ML BAG 250ML, a pharmaceutical product. The contract is not set aside and is a firm fixed-price delivery order with a completion date of May 15, 2025....